Private cancer patients will gain access to publicly funded medicines from 1 December, including Phesgo for HER2-positive breast cancer, sparking debate over equity, cost, and system sustainability.
Stacked weekly counts; colour by editorial lean. Stuff and The Spinoff lean centre-left, NZ Herald centre-right, others centre.
How press outlets have named this topic, week by week.
Most recent 12 articles linking to this topic.
Up to 12 framings spread across outlets. Each framing is the LLM's one-line characterisation of the article's editorial angle — not a quote.
Pasifika women face higher mortality and delayed treatment
Pasifika women still face breast cancer inequities - researcherunderfunding of health services compared to road projects
Letter to the Editor: roads, swamps and syrupy AISocial-media signal on the same topic, drawn from the social lens. Engagement is likes + 2×shares + 3×replies, the same weighting used across the digest cards. View on /social →
Spotted something wrong on this page? Report a correction.
